Hege Hellstrom
Direktor/Vorstandsmitglied bei VIVESTO AB
Vermögen: 147 519 $ am 30.04.2024
Profil
Hege Hellstrom is the founder of Belnor BV.
He currently holds the position of Director at Camurus AB, Independent Non-Executive Director at Vivesto AB, Director at Jane Goddall Institute Belgium, Independent Non-Executive Director at InflaRx NV, and Chief Commercial Officer at Advicenne SA. Previously, Hege held the position of General Manager at Genzyme AB, President at Swedish Orphan Biovitrum AB from 2013 to 2018, and Head-Cardiovascular Unit at Sanofi AB.
Hege's education includes an undergraduate degree from Oslo Metropolitan University and Ullevaal School of Bioengineering.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CAMURUS AB
0,01% | 15.09.2023 | 3 250 ( 0,01% ) | 147 519 $ | 30.04.2024 |
Aktive Positionen von Hege Hellstrom
| Unternehmen | Position | Beginn |
|---|---|---|
| VIVESTO AB | Direktor/Vorstandsmitglied | 26.09.2019 |
| CAMURUS AB | Direktor/Vorstandsmitglied | 07.05.2020 |
| ADVICENNE | Corporate Officer/Principal | 26.05.2020 |
| INFLARX N.V. | Direktor/Vorstandsmitglied | 01.04.2023 |
| Belnor BVBA | Gründer | - |
| Jane Goddall Institute Belgium | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Hege Hellstrom
| Unternehmen | Position | Ende |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Präsident | 01.01.2018 |
Sanofi AB
 Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Corporate Officer/Principal | - |
Genzyme AB
 Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
Ausbildung von Hege Hellstrom
| Ullevaal School of Bioengineering | Undergraduate Degree |
| Oslo Metropolitan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| VIVESTO AB | Health Technology |
| CAMURUS AB | Health Technology |
| ADVICENNE | Health Technology |
| INFLARX N.V. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Genzyme AB
Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Health Technology |
| Belnor BVBA | |
Sanofi AB
Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Distribution Services |
| Jane Goddall Institute Belgium |
